Clin2
NCT07776132Possibly a fitNot yet recruiting

Study of HLX29 compared to HLX11 in healthy men

Health Adult Subjects

This study looks at how the body handles a medication called HLX29 compared to a similar one called HLX11 in healthy men. It helps find the right dose and check for side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
60 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • Male, aged 18 to 45 years old
  • Generally healthy, with no major ongoing illnesses
  • Body mass index (BMI) between 19 and 26
  • Normal heart function (ejection fraction of 55% or higher)
  • No regular use of medications, alcohol, or tobacco

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07495930Not yet recruiting· Phase 1
Testing a biosimilar of Phesgo® in healthy men

This trial tests a new version of a cancer drug (called HLX319) to see how it compares to the approved drug Phesgo®. It is for healthy male volunteers to check how the drug behaves in the body, its safety, and any immune reactions.

Hefei, Anhui
NCT07140081Not yet recruiting· Phase 1
Study of BLX-0871 in healthy volunteers

This trial tests a new medication called BLX-0871 in healthy adults to see how safe it is and how the body processes it. If you are generally healthy and meet the age, weight, and lifestyle requirements, you may be able to join.

Melbourne, New South Wales
NCT07459738Not yet recruiting· Phase 2
Testing HLX43 for advanced hormone-sensitive breast cancer

This study tests a new drug called HLX43 for people whose breast cancer has continued to grow after hormone therapy. The goal is to see if HLX43 can help shrink or control the cancer.

NCT06912295Recruiting· Phase 1
Study of HL-1186 in healthy adults

This study tests a new medicine called HL-1186 in healthy volunteers to see how safe it is and how the body handles it. If you join, you will help researchers gather early information that may lead to future treatments.

Wuxi
NCT07449741Recruiting· Phase 1
Early safety test of HXN6005 in healthy adults

This early-phase study tests an experimental drug called HXN6005 in healthy adults to see how safe it is and how the body handles it. It's looking for volunteers who are generally healthy and meet basic age and weight requirements.

Bayswater, Victoria
NCT07473726Recruiting· Phase 1
Study of a new drug for advanced solid tumors

This trial tests an investigational drug (HLX48) in people with advanced or metastatic solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and how well it works.

North Ryde, New South Wales

Hear when a new Health Adult Subjects trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.